Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
BallerAlert on MSN10h
HBCU Week Foundation Announces 8th Annual HBCU Week in Wilmington and College Fair at Walt Disney WorldThe HBCU Week Foundation is gearing up for its 8th annual HBCU Week Wilmington (DE), presented by AstraZeneca, running from September 22-29, 2024. In addition to the Wilmington festivities, the […] ...
Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...
Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
Key Insights ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback